Ophthalmology Doctors in Wyoming, MI Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Douglas A Doyle, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2221 Health Dr Sw, Wyoming, MI 49519 Phone: 616-252-5710    Fax: 616-252-5780

Paul A. Brown, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2221 Health Dr Sw, Wyoming, MI 49519 Phone: 616-252-5710    Fax: 616-252-5780

Trevor Alan Smith, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2225 Main St Sw Ste 140, Wyoming, MI 49519 Phone: 616-287-5495

Dr. Matthew Jon Borr, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7200

Dr. Jeffrey Neil Holtzman, DO Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2221 Health Dr Sw, Wyoming, MI 49519 Phone: 616-252-5710    Fax: 616-252-5780

News Archive

USPTO terminates interference proceeding in favor of PDL's '089 Patent

PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.

Pre-capillary pulmonary hypertension common in severe heart failure

Pulmonary hypertension is common in patients with heart failure and is likely to include a pre-capillary component, research suggests.

Updated Phase 1 trial results of blinatumomab in patients with relapsed NHL presented at EHA 2010

Micromet, Inc. today announced the presentation of updated results from a Phase 1 trial of the Company's lead product candidate blinatumomab (MT103) in patients with relapsed non-Hodgkin's lymphoma. A high objective response rate was maintained among patients treated with blinatumomab using an adapted schedule, comparable to that previously reported in patients receiving constant dosing.

New device delivers radiation therapy to specific tumor sites

Physicians at the Rebecca and John Moores UCSD Cancer Center will present the initial outcomes of their use of a new device that delivers radiation therapy to a specific tumor site at the annual meeting of the Radiological Society of North America (RSNA), November 25-30, 2007, in Chicago, Illinois.

Read more Medical News

› Verified 9 days ago